|
Tirzepatide is the active ingredient in the popular brands Mounjaro and Zepbound. It is a glucagon-like peptide-1 (GLP-1) receptor agonist drug that has been approved by the U.S. Food and Drug Administration (FDA) as an adjunct to lifestyle changes for weight management in adults who are clinically obese or overweight. It’s also a dual GIP/GLP-1 receptor co-agonist, which means it’s in a class of medications that includes both GIP and GLP-1 receptor agonists.
Address : 14115 Town Loop Blvd Suite 100 Orlando, FL 32837
Email : info@solutionsweightloss.net
Tel : 407-413-5503
|